search
Back to results

Vertebroplasty and Kyphoplasty in Osteoporotic Vertebral Body Fractures.

Primary Purpose

Osteoporotic Fracture of Vertebra

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
vertebroplasty
kyphoplaty
Sponsored by
Assiut University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoporotic Fracture of Vertebra focused on measuring Vertebroplasty, Kyphoplasty, Osteoporosis, Vertebral fractures

Eligibility Criteria

60 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Age: > 60 years.
  2. Sex: both males and females.
  3. Compressive and burst vertebral body fractures without any neurological deficit.
  4. Failure of medical treatment for at least 3-4 weeks

Exclusion Criteria:

  1. Unmanageable bleeding disorder.
  2. Improvement of the symptoms of the patient with conservative management.
  3. Asymptomatic vertebral body fracture or presence of neurological deficit.
  4. Local or generalized infection.
  5. Known allergy to bone cement.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    vertebroplasty

    kyphoplasty

    Arm Description

    Patients will be managed by equipment of vertebroplasty (Osteofix from Tsunami Medical Made in Italy which is composed of a packet of PMMA and ampule of MMA).

    Patients will be managed by equipment of kyphoplasty (Osteofix from Tsunami Medical Made in Italy which is composed of a packet of PMMA and ampule of MMA).

    Outcomes

    Primary Outcome Measures

    back pain
    Measuring and comparing the post-operative back pain via Visual analogue scales system

    Secondary Outcome Measures

    kyphotic deformity
    Measuring and comparing the post-operative via kyphotic deformity Cobb's angle.

    Full Information

    First Posted
    September 19, 2018
    Last Updated
    September 20, 2018
    Sponsor
    Assiut University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03682328
    Brief Title
    Vertebroplasty and Kyphoplasty in Osteoporotic Vertebral Body Fractures.
    Official Title
    Comparetive Study Between Vertebroplasty and Kyphoplasty in the Management of Osteoporotic Vertebral Body Fractures.
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    September 2018
    Overall Recruitment Status
    Unknown status
    Study Start Date
    October 1, 2018 (Anticipated)
    Primary Completion Date
    August 1, 2020 (Anticipated)
    Study Completion Date
    September 1, 2020 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Assiut University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Vertebral body fractures are a major health care problem in all countries with incidence 1.4%. They are a common cause of severe debilitating pain, with consequent deteriorated quality of life, physical function and psychosocial performance. Surgery is indicated in patients with vertebral body fracture, and concurrent spinal instability or neurologic deficit. The cornerstone of management for vertebral body fractures without neurological impairment is medical therapy, which include analgesics, bed rest, orthoses and rehabilitation. In the majority of patients such treatment modalities are effective. However, conservative management measures are not indicated for every type of fracture. For example, in older patients with vertebral fractures and cardio-respiratory disease it is not possible to prescribe bedrest for long period. Moreover, sometimes anti-inflammatory drugs are poorly tolerated by older patients, and bed rest can lead to further demineralization of the vertebrae, predisposing to future fractures. Percutaneous minimally invasive vertebral augmentation methods for cement application into the vertebral body are a useful tool for the management of symptomatic fractures without neurological impairment when conventional measures of treatment can not be adopted. Two different percutaneous minimally invasive vertebral augmentation methods for cement application into the vertebral body for the management of symptomatic vertebral body fractures without neurological impairment have been developed, namely vertebroplasty and kyphoplasty. Kyphoplasty and vertebroplasty have gained wide acceptance worldwide to manage patients without neurological impairment suffering from unmanageable pain caused by vertebral body fractures. Both procedures depend on mechanical stabilization of the fracture produced by cement injection into the fractured vertebral body. Cement augmentation of the vertebral body by vertebroplasty and kyphoplasty was originally introduced for osteoporotic compression fractures, but surgeons have now applied these techniques as a method of enhancing anterior column support while avoiding the morbidity and complications associated with anterior approaches. The mainstay of the controversy between kyphoplasty and vertebroplasty are height restoration, whether or not this height restoration is clinically significant, and the risks related to height restoration.
    Detailed Description
    This study is a Randomized interventional study to be done at neurosurgery department, Assiut Universitu Hospital, Assiut university, Egypt. Vertebroplasty To achieve a low complication rate, the most important factor which influences the result of the vertebroplasty is the visualization of needle placement and cement application. Vertebroplasty may be performed using both fluoroscopy, and CT scanning to obtain an accurate visualization of needle position and cement distribution. The monitoring of the distribution of the cement under direct fluoroscopic control is another crucial aspect of the procedure, independently from the technique used for needle placement. Vertebroplasty can be performed under local anaesthesia or a combination of conscious sedation in most patients, and is therefore particularly useful in patients with risk factors for general anaesthesia. General anaesthesia is required only in patients unable to cooperate due to pain or in very agitated patients. The access path depends on the level of the vertebral segment to be injected. In the lumbar spine, a transpedicular route is preferred. In the thoracic vertebrae, an intercostovertebral access is recommended. In the cervical vertebrae, an anterolateral approach is used. The cement should be injected while in its tooth-paste like phase to minimize complications from extravasation in the surrounding tissues, as the flow characteristics of the cement change over the time. Cement injection may be stopped when the anterior two thirds of the vertebral body are filled and the cement is homogenously distributed between both endplates. During cement injection, continuous fluoroscopic monitoring is performed to immediately detect extravasations of cement. In case of extravasation, the procedure must be interrupted. A direct correlation between the risk of extraosseous extravasation and the amount of cement injection has been proposed, but, to date, no studies have addressed the specific issue of the volume of cement needed during vertebroplasty. Normally, 2.5-4 mL of cement should provide good filling of the vertebra and achieve both consolidation and pain relief in patients with osteoporotic fractures. Kyphoplasty Kyphoplasty is normally performed under general anaesthesia in some patients as proper placement of the balloons is mandatory, and several steps need to be taken before cement can be injected. A mono- or bilateral trans- or para-pedicular approach is used to insert a working cannula into the posterior aspect of the vertebral body. The procedure is performed under fluoroscopy or CT scan control. With reaming tools, two working channels within the anterior aspect of the vertebral body are produced, and the appropriate balloon is inserted. To reduce the fractured vertebra and to produce a cavity, the balloon is inflated using visual volume and pressure controls. The behaviour of the vertebral body is monitored under fluoroscopic control. Inflation is stopped when a pressure above 250 psi is obtained, when the balloon contacts the cortical surface of the vertebral body, or if the balloon expands beyond the border of the vertebral body, and if the height of the vertebra is restored. Successively, the balloons are retracted and cement polymethylmetacrylate (PMMA) is injected using a blunt cannula under continuous fluoroscopic control.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Osteoporotic Fracture of Vertebra
    Keywords
    Vertebroplasty, Kyphoplasty, Osteoporosis, Vertebral fractures

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    Randomized Controlled Trial
    Masking
    Participant
    Allocation
    Randomized
    Enrollment
    23 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    vertebroplasty
    Arm Type
    Active Comparator
    Arm Description
    Patients will be managed by equipment of vertebroplasty (Osteofix from Tsunami Medical Made in Italy which is composed of a packet of PMMA and ampule of MMA).
    Arm Title
    kyphoplasty
    Arm Type
    Active Comparator
    Arm Description
    Patients will be managed by equipment of kyphoplasty (Osteofix from Tsunami Medical Made in Italy which is composed of a packet of PMMA and ampule of MMA).
    Intervention Type
    Procedure
    Intervention Name(s)
    vertebroplasty
    Intervention Description
    Cement augmentation of the vertebral body
    Intervention Type
    Procedure
    Intervention Name(s)
    kyphoplaty
    Intervention Description
    Cement augmentation of the vertebral body
    Primary Outcome Measure Information:
    Title
    back pain
    Description
    Measuring and comparing the post-operative back pain via Visual analogue scales system
    Time Frame
    up to 6 months
    Secondary Outcome Measure Information:
    Title
    kyphotic deformity
    Description
    Measuring and comparing the post-operative via kyphotic deformity Cobb's angle.
    Time Frame
    up to 6 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    60 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Age: > 60 years. Sex: both males and females. Compressive and burst vertebral body fractures without any neurological deficit. Failure of medical treatment for at least 3-4 weeks Exclusion Criteria: Unmanageable bleeding disorder. Improvement of the symptoms of the patient with conservative management. Asymptomatic vertebral body fracture or presence of neurological deficit. Local or generalized infection. Known allergy to bone cement.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Mahmoud Gamal, M.Sc
    Phone
    +201000630887
    Email
    mahmoud_gamal20102000@yahoo.com
    First Name & Middle Initial & Last Name or Official Title & Degree
    Mohammad Taghyan, MD
    Phone
    01006876892
    Email
    mtoghyan@hotmail.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Ahmed Abdalla, MD
    Organizational Affiliation
    Assiut University
    Official's Role
    Study Chair

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided
    Citations:
    PubMed Identifier
    16291128
    Citation
    Lieberman IH, Togawa D, Kayanja MM. Vertebroplasty and kyphoplasty: filler materials. Spine J. 2005 Nov-Dec;5(6 Suppl):305S-316S. doi: 10.1016/j.spinee.2005.02.020.
    Results Reference
    background
    PubMed Identifier
    12897474
    Citation
    Phillips FM. Minimally invasive treatments of osteoporotic vertebral compression fractures. Spine (Phila Pa 1976). 2003 Aug 1;28(15 Suppl):S45-53. doi: 10.1097/01.BRS.0000076898.37566.32.
    Results Reference
    background

    Learn more about this trial

    Vertebroplasty and Kyphoplasty in Osteoporotic Vertebral Body Fractures.

    We'll reach out to this number within 24 hrs